Gloshell
Ingredients

Ingredient Dictionary

METHOXYCYCLODODECANE

Molecular structure

Definition

US FDA substance register · UNII 6PH8G80V14 · registered name PALISANDIN · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Gives the product a scentPERFUMING

Safety & regulatory references

Restricted
International fragrance standard (IFRA)

Source: IFRA fragrance standards

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

More data — names, identifiers, properties, test records, literature

Names & identifiers

METHOXYCYCLODODECANEINCICyclododecane, methoxy-Synonym
CAS No.chemical registry number
2986-54-1
EC No.EU chemical inventory number
221-053-8
DTXSIDUS EPA chemical ID
DTXSID1062758
DTXCIDUS EPA compound ID
DTXCID6038085
IUPAC
Methoxycyclododecane
Molecular formula
C13H26O
Molecular weight
198.35 g/mol

Measured properties

Appearance
liquid
Melting/freezing point
5.22 ℃
Initial boiling point and range
268~270 ℃
Flash point
118 ℃(100 hPa)
Vapour pressure
㎩ (at 25°C)
Water solubility
4.11 ㎎/ℓ
Vapour density
6.846392820158785
Relative density
1.319
n-Octanol/water partition coefficient (Kow)
5.061
Molecular weight
198.34

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: KOSHA safety data sheets (Korea)

What products actually use it for

What the 3 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Fragrance3

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

3 skin studies and 1 eye studies are on record.

Classed as highly irritating2

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 4 studies
  • High Frequency of Sensitization
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) (adopted July 2010) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) 29 April 2004
  • SkinIrr2
    Skin Irritation · QSAR Predicted
  • Corrosive
    skin corrosion: in vitro / ex vivo · Screening · OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method) (adopted 22 July 2010) according to EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) Feb 1987 according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) Jan 1997 according to

Source: US EPA CompTox dashboard

Linked databases 12